Newsroom press releases

16/12/21 - 22:47

DiaSorin 2022-2025 Strategic Plan (552.15 KB)

Financial Data

11/11/21 - 16:56

DiaSorin business momentum and the Luminex acquisition drive Revenues and Profitability up in the first 9 months of 2021 (862.48 KB)

Financial Data

30/07/21 - 12:57

DiaSorin: Revenues and Profitability continue upward momentum in the First Half of 2021, with Guidance raised following the acquisition of Luminex (774.36 KB)

Financial Data

14/07/21 - 15:05

DiaSorin announces completion of the Acquisition of Luminex Corporation (566.52 KB)

Acquisition / Partnership

09/07/21 - 7:34

DiaSorin obtains all approvals necessary to complete the acquisition of Luminex (560.68 KB)

Acquisition / Partnership

21/06/21 - 18:49

The Shareholders’ meeting of Luminex Corporation approved the merger of Luminex with a U.S. wholly-owned subsidiary of DiaSorin (395.62 KB)

Acquisition / Partnership

03/06/21 - 7:47

DiaSorin signs agreements with Unifarma and Alliance Healthcare for the distribution in Italian pharmacies of the LIAISON® IQ (523.42 KB)

Acquisition / Partnership

14/05/21 - 16:10

DiaSorin: significant growth in Revenues and Profitability in the first quarter 2021 (756.07 KB)

Financial Data

28/04/21 - 17:46

DiaSorin successfully prices its offer of € 500 million Senior Unsecured Equity-Linked Bonds due 2028 (529.64 KB)

Financial Data

28/04/21 - 7:54

DiaSorin announces its intention to offer € 500 million senior unsecured equity-linked bonds due 2028 (563.02 KB)

Financial Data

11/04/21 - 19:47

DiaSorin to acquire Luminex Corporation for USD 37.00 per share or approximately USD 1.8 billion (569.09 KB)

Acquisition / Partnership

06/04/21 - 7:06

DiaSorin announces its strategic collaboration with Lumos Diagnostics (438.14 KB)

Acquisition / Partnership

11/03/21 - 16:37

Dividend coupon date correction (414.99 KB)

Financial Data

11/03/21 - 15:31

Revenues, Profitability and Cash Flow Generation hit record highs in 2020 (748.06 KB)

Financial Data